HK Stock MarketDetailed Quotes

06955 BOAN BIOTECH

Watchlist

8.570
+0.790+10.15%

Market Closed Dec 2 16:08 CST

4.59BMarket Cap68.02P/E (TTM)

BOAN BIOTECH Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

Cash flow from operating activities

Earning before tax

151.71%61.67M

64.02%-119.38M

22.19%-119.27M

-47.17%-331.75M

-19.83%-153.3M

6.29%-225.42M

---127.93M

---240.54M

Profit adjustment

Interest (income) - adjustment

75.09%-266K

79.18%-1.16M

72.54%-1.07M

38.82%-5.57M

11.97%-3.89M

-661.59%-9.1M

---4.42M

---1.2M

Impairment and provisions:

573.08%123K

-200.00%-26K

--26K

----

-Impairment of trade receivables (reversal)

573.08%123K

-200.00%-26K

--26K

----

Asset sale loss (gain):

----

-75.76%16K

-95.38%3K

500.00%66K

--65K

--11K

-Loss (gain) on sale of property, machinery and equipment

----

-75.76%16K

-95.38%3K

500.00%66K

--65K

--11K

Depreciation and amortization:

-34.46%28.31M

13.63%82.77M

19.63%43.2M

45.64%72.84M

103.52%36.11M

214.88%50.01M

--17.74M

--15.88M

-Amortization of intangible assets

-29.25%8.78M

45.14%25.45M

51.62%12.4M

58.93%17.54M

170.36%8.18M

320.66%11.03M

--3.03M

--2.62M

Financial expense

101.37%12.6M

5.07%14.09M

-5.54%6.26M

15.59%13.41M

18.78%6.62M

-1.86%11.6M

--5.58M

--11.82M

Exchange Loss (gain)

----

204.00%2.83M

-4.16%-2.83M

-155.00%-2.72M

-657.91%-2.72M

--4.95M

--487K

----

Special items

0.56%10.29M

11.69%20.64M

12.71%10.24M

-13.14%18.48M

28.55%9.08M

--21.28M

--7.06M

----

Operating profit before the change of operating capital

277.49%112.73M

99.90%-238K

41.22%-63.51M

-60.47%-235.28M

-6.56%-108.06M

31.49%-146.62M

---101.41M

---214.02M

Change of operating capital

Inventory (increase) decrease

66.35%-4.84M

51.65%-21.66M

65.82%-14.37M

43.42%-44.79M

-40.04%-42.04M

-362.54%-79.17M

---30.02M

---17.12M

Accounts receivable (increase)decrease

-2,575.58%-94.27M

42.60%-60.21M

111.98%3.81M

1.58%-104.88M

-199.98%-31.79M

-2,231.34%-106.57M

---10.6M

--5M

Accounts payable increase (decrease)

-318.05%-82.84M

-46.86%72.6M

9.57%37.99M

49.57%136.61M

166.80%34.67M

132.83%91.33M

--13M

---278.23M

prepayments (increase)decrease

61.34%11.07M

-137.78%-9.27M

-33.27%6.86M

466.36%24.54M

310.44%10.28M

70.80%-6.7M

---4.88M

---22.93M

Special items for working capital changes

695.30%8.64M

-99.06%207K

-95.22%1.09M

1,424.36%21.97M

227.83%22.72M

-93.00%1.44M

---17.78M

--20.58M

Cash from business operations

-75.96%-49.51M

90.80%-18.57M

75.36%-28.14M

18.04%-201.84M

24.71%-114.21M

51.40%-246.28M

---151.69M

---506.72M

Net cash from operations

-75.96%-49.51M

90.80%-18.57M

75.36%-28.14M

18.04%-201.84M

24.71%-114.21M

51.40%-246.28M

---151.69M

---506.72M

Cash flow from investment activities

Interest received - investment

-74.95%266K

-79.15%1.19M

-73.69%1.06M

-36.40%5.69M

-0.17%4.04M

28,767.74%8.95M

--4.04M

--31K

Loan receivable (increase) decrease

----

--112.46M

Decrease in deposits (increase)

----

200.00%100M

----

---100M

----

Purchase of fixed assets

4.48%-58.82M

17.18%-67.32M

-57.41%-61.57M

24.54%-81.29M

38.55%-39.12M

-330.00%-107.73M

---63.66M

---25.05M

Purchase of intangible assets

-135.14%-190.64M

-81.82%-227.43M

-29.67%-81.07M

46.43%-125.09M

37.85%-62.52M

-119.84%-233.52M

---100.61M

---106.22M

Net cash from investment operations

-76.00%-249.19M

-191.58%-293.57M

-45.06%-141.59M

76.71%-100.68M

62.49%-97.6M

-2,201.04%-432.3M

---260.22M

---18.79M

Net cash before financing

-75.99%-298.7M

-3.18%-312.14M

19.87%-169.72M

55.42%-302.53M

48.58%-211.82M

-29.13%-678.57M

---411.91M

---525.51M

Cash flow from financing activities

New borrowing

3,837.71%324.11M

153.34%134.22M

23.22%8.23M

1,772.05%52.98M

136.04%6.68M

-99.68%2.83M

--2.83M

--886.08M

Refund

-195.43%-44.32M

-200.00%-30M

-200.00%-15M

---10M

---5M

----

---1.15B

Issuing shares

----

--189.16M

----

Interest paid - financing

-39.00%-8.99M

-8.13%-14.11M

2.34%-6.47M

-12.48%-13.05M

-25.39%-6.62M

1.86%-11.6M

---5.28M

---11.82M

Absorb investment income

----

54.11%1.23B

--1.02B

--798.27M

Issuance expenses and redemption of securities expenses

----

-3,571.28%-10.61M

-588.97%-937K

---289K

---136K

----

Pledged bank deposit (increase) decrease

----

200.00%200M

--200M

---200M

----

Net cash from financing operations

47.09%269.04M

223,002.36%283.09M

1,695.77%182.91M

-100.01%-127K

-101.13%-11.46M

129.83%1.21B

--1.02B

--527.23M

Effect of rate

-102.07%-68K

-158.35%-2.6M

-13.84%3.29M

187.52%4.45M

925.97%3.82M

---5.08M

---462K

----

Net Cash

-324.94%-29.66M

90.40%-29.05M

105.91%13.19M

-156.77%-302.65M

-136.95%-223.28M

30,789.63%533.16M

--604.31M

--1.73M

Begining period cash

-13.55%201.85M

-56.08%233.5M

14,551.50%531.7M

90.70%3.63M

--3.63M

--1.9M

Cash at the end

-31.14%172.12M

-13.55%201.85M

-19.94%249.97M

-56.08%233.5M

-48.60%312.24M

14,551.50%531.7M

--607.47M

--3.63M

Cash balance analysis

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young

	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020
Cash flow from operating activities
Earning before tax	151.71%61.67M	64.02%-119.38M	22.19%-119.27M	-47.17%-331.75M	-19.83%-153.3M	6.29%-225.42M	---127.93M	---240.54M
Profit adjustment
Interest (income) - adjustment	75.09%-266K	79.18%-1.16M	72.54%-1.07M	38.82%-5.57M	11.97%-3.89M	-661.59%-9.1M	---4.42M	---1.2M
Impairment and provisions:	573.08%123K	-200.00%-26K	-200.00%-26K	--26K	--26K	----	----	----
-Impairment of trade receivables (reversal)	573.08%123K	-200.00%-26K	-200.00%-26K	--26K	--26K	----	----	----
Asset sale loss (gain):	----	----	----	-75.76%16K	-95.38%3K	500.00%66K	--65K	--11K
-Loss (gain) on sale of property, machinery and equipment	----	----	----	-75.76%16K	-95.38%3K	500.00%66K	--65K	--11K
Depreciation and amortization:	-34.46%28.31M	13.63%82.77M	19.63%43.2M	45.64%72.84M	103.52%36.11M	214.88%50.01M	--17.74M	--15.88M
-Amortization of intangible assets	-29.25%8.78M	45.14%25.45M	51.62%12.4M	58.93%17.54M	170.36%8.18M	320.66%11.03M	--3.03M	--2.62M
Financial expense	101.37%12.6M	5.07%14.09M	-5.54%6.26M	15.59%13.41M	18.78%6.62M	-1.86%11.6M	--5.58M	--11.82M
Exchange Loss (gain)	----	204.00%2.83M	-4.16%-2.83M	-155.00%-2.72M	-657.91%-2.72M	--4.95M	--487K	----
Special items	0.56%10.29M	11.69%20.64M	12.71%10.24M	-13.14%18.48M	28.55%9.08M	--21.28M	--7.06M	----
Operating profit before the change of operating capital	277.49%112.73M	99.90%-238K	41.22%-63.51M	-60.47%-235.28M	-6.56%-108.06M	31.49%-146.62M	---101.41M	---214.02M
Change of operating capital
Inventory (increase) decrease	66.35%-4.84M	51.65%-21.66M	65.82%-14.37M	43.42%-44.79M	-40.04%-42.04M	-362.54%-79.17M	---30.02M	---17.12M
Accounts receivable (increase)decrease	-2,575.58%-94.27M	42.60%-60.21M	111.98%3.81M	1.58%-104.88M	-199.98%-31.79M	-2,231.34%-106.57M	---10.6M	--5M
Accounts payable increase (decrease)	-318.05%-82.84M	-46.86%72.6M	9.57%37.99M	49.57%136.61M	166.80%34.67M	132.83%91.33M	--13M	---278.23M
prepayments (increase)decrease	61.34%11.07M	-137.78%-9.27M	-33.27%6.86M	466.36%24.54M	310.44%10.28M	70.80%-6.7M	---4.88M	---22.93M
Special items for working capital changes	695.30%8.64M	-99.06%207K	-95.22%1.09M	1,424.36%21.97M	227.83%22.72M	-93.00%1.44M	---17.78M	--20.58M
Cash from business operations	-75.96%-49.51M	90.80%-18.57M	75.36%-28.14M	18.04%-201.84M	24.71%-114.21M	51.40%-246.28M	---151.69M	---506.72M
Net cash from operations	-75.96%-49.51M	90.80%-18.57M	75.36%-28.14M	18.04%-201.84M	24.71%-114.21M	51.40%-246.28M	---151.69M	---506.72M
Cash flow from investment activities
Interest received - investment	-74.95%266K	-79.15%1.19M	-73.69%1.06M	-36.40%5.69M	-0.17%4.04M	28,767.74%8.95M	--4.04M	--31K
Loan receivable (increase) decrease	----	----	----	----	----	----	----	--112.46M
Decrease in deposits (increase)	----	----	----	200.00%100M	----	---100M	---100M	----
Purchase of fixed assets	4.48%-58.82M	17.18%-67.32M	-57.41%-61.57M	24.54%-81.29M	38.55%-39.12M	-330.00%-107.73M	---63.66M	---25.05M
Purchase of intangible assets	-135.14%-190.64M	-81.82%-227.43M	-29.67%-81.07M	46.43%-125.09M	37.85%-62.52M	-119.84%-233.52M	---100.61M	---106.22M
Net cash from investment operations	-76.00%-249.19M	-191.58%-293.57M	-45.06%-141.59M	76.71%-100.68M	62.49%-97.6M	-2,201.04%-432.3M	---260.22M	---18.79M
Net cash before financing	-75.99%-298.7M	-3.18%-312.14M	19.87%-169.72M	55.42%-302.53M	48.58%-211.82M	-29.13%-678.57M	---411.91M	---525.51M
Cash flow from financing activities
New borrowing	3,837.71%324.11M	153.34%134.22M	23.22%8.23M	1,772.05%52.98M	136.04%6.68M	-99.68%2.83M	--2.83M	--886.08M
Refund	-195.43%-44.32M	-200.00%-30M	-200.00%-15M	---10M	---5M	----	----	---1.15B
Issuing shares	----	----	----	--189.16M	----	----	----	----
Interest paid - financing	-39.00%-8.99M	-8.13%-14.11M	2.34%-6.47M	-12.48%-13.05M	-25.39%-6.62M	1.86%-11.6M	---5.28M	---11.82M
Absorb investment income	----	----	----	----	----	54.11%1.23B	--1.02B	--798.27M
Issuance expenses and redemption of securities expenses	----	----	----	-3,571.28%-10.61M	-588.97%-937K	---289K	---136K	----
Pledged bank deposit (increase) decrease	----	200.00%200M	--200M	---200M	----	----	----	----
Net cash from financing operations	47.09%269.04M	223,002.36%283.09M	1,695.77%182.91M	-100.01%-127K	-101.13%-11.46M	129.83%1.21B	--1.02B	--527.23M
Effect of rate	-102.07%-68K	-158.35%-2.6M	-13.84%3.29M	187.52%4.45M	925.97%3.82M	---5.08M	---462K	----
Net Cash	-324.94%-29.66M	90.40%-29.05M	105.91%13.19M	-156.77%-302.65M	-136.95%-223.28M	30,789.63%533.16M	--604.31M	--1.73M
Begining period cash	-13.55%201.85M	-56.08%233.5M	-56.08%233.5M	14,551.50%531.7M	14,551.50%531.7M	90.70%3.63M	--3.63M	--1.9M
Cash at the end	-31.14%172.12M	-13.55%201.85M	-19.94%249.97M	-56.08%233.5M	-48.60%312.24M	14,551.50%531.7M	--607.47M	--3.63M
Cash balance analysis
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion
Auditor	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

06955 BOAN BIOTECH

BOAN BIOTECH Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target